Intrinsic Value of S&P & Nasdaq Contact Us

Legend Biotech Corporation LEGN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
58/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$58.60
+213.5%

Stock Statistics — LEGN

Legend Biotech Corporation (LEGN) has a market capitalization of $3.46B and trades at $18.69. The 52-week range is 16.24-45.297.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -11.7, Earnings Per Share (EPS) of $-1.60, annual revenue of $1.03B.

The stock has a beta of 0.08, operates in the Healthcare sector.

Trading Data
Current Price$18.69
52-Week Range16.24-45.297
Volume2.7M
Avg Volume (30D)2.13M
Market Cap$3.46B
Beta (1Y)0.08
Company
IPO Date2020-06-05
Employees2,600
CEOYing Huang
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS52490G1022
CUSIP52490G102
Income (Latest Year)
Revenue$1.03B
Gross Profit$622.44M
EBITDA$-107.78M
Operating Income$-136.86M
Net Income$-297.58M
EPS$-1.60
EPS Diluted$-1.60
Shares Outstanding$184.32M
Balance Sheet (Latest Year)
Total Assets$1.73B
Current Assets$1.25B
Cash & ST Investments$948.6M
Total Liabilities$723.6M
Total Debt$413.7M
Net Debt$-488.2M
Total Equity$1B
Debt / Equity0.41
Valuation Ratios
P/E Ratio-11.7
P/S Ratio3.35
P/B Ratio3.45
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message